Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

No interaction between desipramine and bromperidol

A Suzuki1, K Otani, M Ishida

  • 1Department of Neuropsychiatry, Hirosaki University Hospital, Japan.

Progress in Neuro-Psychopharmacology & Biological Psychiatry
|October 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Characterization of nucleotide sequences that interact with a nuclear protein fraction in rRNA gene of Vicia faba.

Plant molecular biology·1992
Same author

[Surgical treatment of infected left atrial myxoma--a case report].

[Zasshi] [Journal]. Nihon Kyobu Geka Gakkai·1992
Same author

Effect of aminophylline on brain tissue oxygenation in patients with chronic obstructive lung disease.

Thorax·1992
Same author

cDNA cloning and sequence determination of the pheromone biosynthesis activating neuropeptide of the silkworm, Bombyx mori.

Biochemical and biophysical research communications·1992
Same author

A carboxyl-terminal truncated version of the activin receptor mediates activin signals in early Xenopus embryos.

FEBS letters·1992
Same author

Mechanism of the reflex inhibition of micturition contractions of the urinary bladder elicited by acupuncture-like stimulation in anesthetized rats.

Neuroscience research·1992

Coadministration of desipramine did not alter bromperidol plasma concentrations or clinical outcomes in schizophrenic patients. This suggests no significant drug interaction between desipramine and bromperidol.

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Psychiatry

Background:

  • Bromperidol is an antipsychotic medication used in schizophrenia treatment.
  • Desipramine is a tricyclic antidepressant that is a substrate of CYP2D6.
  • Understanding drug interactions is crucial for optimizing patient therapy.

Purpose of the Study:

  • To investigate the pharmacokinetic interaction between bromperidol and desipramine.
  • To evaluate the clinical impact of coadministering desipramine with bromperidol in schizophrenic patients.

Main Methods:

  • 13 schizophrenic inpatients received bromperidol (12.24 mg/day) for 1-20 weeks.
  • Desipramine (50 mg/day) was coadministered for 1 week.
  • Plasma concentrations of bromperidol and its reduced metabolite were measured using HPLC.

Related Experiment Videos

  • Clinical Global Impression (CGI) and Udvalg for Kliniske Undersøgelser (UKU) scores were assessed.

    • Main Results:

    • Desipramine coadministration did not significantly change plasma concentrations of bromperidol (9.6 +/- 4.5 vs. 9.6 +/- 2.8 ng/ml).
    • Plasma concentrations of reduced bromperidol also remained unchanged (2.8 +/- 2.5 vs. 2.8 +/- 2.1 ng/ml).
    • No significant changes were observed in CGI or UKU scores post-coadministration.

    Conclusions:

    • The study suggests no significant pharmacokinetic or clinical interaction between desipramine and bromperidol.
    • Desipramine does not appear to affect bromperidol metabolism via CYP2D6 in this patient population.
    • Further research may be warranted to confirm these findings in a broader population.